12/10/2021 7:03:12 AM
Kezar Appoints Courtney Wallace To Board
10/27/2021 8:18:32 AM
Kezar Says First Patient Dosed In Phase 1 Trial Of KZR-261 In Advanced Solid Tumor Malignancies
10/5/2021 4:06:43 PM
Kezar Life Sciences Appoints Gitanjali Jain As VP, Investor Relations And External Affairs
8/23/2021 7:06:15 AM
Kezar Life Sciences Completes Enrollment Of Phase 2 PRESIDIO Trial Of KZR-616 In Polymyositis And Dermatomyositis
3/12/2019 7:16:29 AM
William Blair Reiterates Kezar Life Sciences, Inc. (KZR) At Outperform